A broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis
- PMID: 19720992
- PMCID: PMC2747210
- DOI: 10.1073/pnas.0908032106
A broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis
Abstract
Deposits of Ig and complement are abundant in affected joints of patients with rheumatoid arthritis (RA) and in animal models of RA in which antibodies are demonstrably pathogenic. To identify molecular targets of the Igs deposited in arthritic joints, which may activate local inflammation, we used a combination of mass spectrometry (MS) and protein microarrays. Immune complexes were affinity-purified from surgically removed joint tissues of 26 RA and osteoarthritis (OA) patients. Proteins complexed with IgG were identified by proteomic analysis using tandem MS. A striking diversity of components of the extracellular matrix, and some intracellular components, copurified specifically with IgG from RA and OA tissues. A smaller set of autoantigens was observed only in RA eluates. In complementary experiments, IgG fractions purified from joint immune complexes were tested on protein microarrays against a range of candidate autoantigens. These Igs bound a diverse subset of proteins and peptides from synovium and cartilage, different from that bound by normal serum Ig. One type of intracellular protein detected specifically in RA joints (histones H2A/B) was validated by immunohistology and found to be deposited on the cartilage surface of RA but not OA joints. Thus, autoantibodies to many determinants (whether deposited as "neoantigens" or normal constituents of the extracellular matrix) have the potential to contribute to arthritic inflammation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Cy3-tilmanocept labeling of macrophages in joints of mice with antibody-induced arthritis and synovium of human patients with rheumatoid arthritis.J Orthop Res. 2021 Apr;39(4):821-830. doi: 10.1002/jor.24900. Epub 2020 Dec 15. J Orthop Res. 2021. PMID: 33107629
-
Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach.Arthritis Res Ther. 2006;8(6):R175. doi: 10.1186/ar2085. Arthritis Res Ther. 2006. PMID: 17125526 Free PMC article.
-
The differential expressions of 78-kDa glucose-regulated protein of infiltrating plasma cells in peripheral joints with the histopathological variants of rheumatoid synovitis.Arthritis Res Ther. 2009 Jan 9;11(1):R4. doi: 10.1186/ar2588. Arthritis Res Ther. 2009. PMID: 19128512 Free PMC article.
-
Tenascin-C in Osteoarthritis and Rheumatoid Arthritis.Front Immunol. 2020 Sep 30;11:577015. doi: 10.3389/fimmu.2020.577015. eCollection 2020. Front Immunol. 2020. PMID: 33101302 Free PMC article. Review.
-
[The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences].Z Rheumatol. 2001 Feb;60(1):1-16. doi: 10.1007/s003930170093. Z Rheumatol. 2001. PMID: 11263010 Review. German.
Cited by
-
Elevated Anti-Citrullinated Protein Antibodies Prior to Rheumatoid Arthritis Diagnosis and Risks for Chronic Obstructive Pulmonary Disease or Asthma.Arthritis Care Res (Hoboken). 2021 Apr;73(4):498-509. doi: 10.1002/acr.24140. Arthritis Care Res (Hoboken). 2021. PMID: 31961487 Free PMC article.
-
Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.Ann Rheum Dis. 2014 Aug;73(8):1487-94. doi: 10.1136/annrheumdis-2012-203160. Epub 2013 May 28. Ann Rheum Dis. 2014. PMID: 23716070 Free PMC article.
-
The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes.EMBO Mol Med. 2013 Feb;5(2):235-49. doi: 10.1002/emmm.201201846. Epub 2012 Dec 11. EMBO Mol Med. 2013. PMID: 23165896 Free PMC article.
-
Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.Ann Rheum Dis. 2016 Oct;75(10):1876-83. doi: 10.1136/annrheumdis-2015-208495. Epub 2015 Dec 9. Ann Rheum Dis. 2016. PMID: 26659718 Free PMC article.
-
Disease-Specific Autoantibodies Induce Trained Immunity in RA Synovial Tissues and Its Gene Signature Correlates with the Response to Clinical Therapy.Mediators Inflamm. 2020 Oct 6;2020:2109325. doi: 10.1155/2020/2109325. eCollection 2020. Mediators Inflamm. 2020. PMID: 33082707 Free PMC article.
References
-
- Vander Cruyssen B, et al. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor. Autoimmun Rev. 2005;4:468–474. - PubMed
-
- Edwards JC, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004;350:2572–2581. - PubMed
-
- Monach PA, Benoist C, Mathis D. The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv Immunol. 2004;82:217–248. - PubMed
-
- Ronnelid J, Lysholm J, Engstrom-Laurent A, Klareskog L, Heyman B. Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum. 1994;37:1023–1029. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical